Sartorius Stedim Biotech, a global leader in biopharmaceutical solutions based in Aubagne, France, has joined forces with Bio Usawa Biotechnology to revolutionize Africa’s biopharmaceutical industry. This groundbreaking partnership aims to address the continent’s pressing health challenges by developing affordable monoclonal antibodies to combat a range of diseases.
With a focus on oncology, diabetes-induced eye conditions, infectious diseases, and autoimmune disorders, the collaboration is set to transform healthcare access in Sub-Saharan Africa. Through cutting-edge research and development, workforce capacity building, and technology enablement, Sartorius Stedim Biotech and Bio Usawa Biotechnology are paving the way for a new era of innovation and accessibility in African biopharmaceutical manufacturing.
Read more from finance.yahoo.com